U.S. markets open in 9 hours 20 minutes
  • S&P Futures

    4,153.25
    +11.50 (+0.28%)
     
  • Dow Futures

    32,876.00
    +84.00 (+0.26%)
     
  • Nasdaq Futures

    13,221.50
    +38.25 (+0.29%)
     
  • Russell 2000 Futures

    1,947.00
    +5.90 (+0.30%)
     
  • Crude Oil

    90.61
    -0.15 (-0.17%)
     
  • Gold

    1,802.00
    -3.20 (-0.18%)
     
  • Silver

    20.69
    +0.08 (+0.37%)
     
  • EUR/USD

    1.0196
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    2.7650
    -0.0750 (-2.64%)
     
  • Vix

    21.29
    +0.14 (+0.66%)
     
  • GBP/USD

    1.2081
    -0.0001 (-0.01%)
     
  • USD/JPY

    134.9580
    -0.0150 (-0.01%)
     
  • BTC-USD

    23,843.99
    +540.56 (+2.32%)
     
  • CMC Crypto 200

    556.92
    +14.04 (+2.59%)
     
  • FTSE 100

    7,482.37
    +42.63 (+0.57%)
     
  • Nikkei 225

    28,013.02
    -236.22 (-0.84%)
     

Semiconductor Shortages - See How ResMed Is Tackling

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • ResMed Inc (NYSE: RMD) has redesigned the AirSense 10 to eliminate a short-supply semiconductor chipset used for cellular communications chips.

  • Instead of offering wireless communications capability, the new AirSense 10 "Card to Cloud" models collect the patient's data on an SD card, which can then be mailed to the provider and uploaded to the cloud.

  • Needham notes that ResMed continues to sell its AirSense 10 and AirSense 11 models with cellular connectivity.

  • The AirSense 10 Card to Cloud is now available in the U.S. and select international geographies.

  • Related: ResMed Strengthens Its Out-Of-Hospital Software Solutions Position With Latest Acquisition - Read How.

  • At a recent investor conference, management noted that the redesigns have freed up some CPAP volume, and they expect this to be aided by RMD's new 450,000-square-foot manufacturing facility in Singapore.

  • Management also noted their flexibility with their supply chain and reengineering capabilities should allow for sequential revenue growth throughout CY22.

  • Needham says that a check at internet retailers indicates better availability of ResMed flow generators, including the AirSense 10 Card to Cloud.

  • Price Action: RMD shares are down 1.03% at $230.51 during the market session on the last check Friday.

Latest Ratings for RMD

Date

Firm

Action

From

To

Jan 2022

Citigroup

Upgrades

Neutral

Buy

Jan 2022

RBC Capital

Upgrades

Underperform

Sector Perform

Jan 2022

JP Morgan

Upgrades

Neutral

Overweight

View More Analyst Ratings for RMD

View the Latest Analyst Ratings

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.